Biotech | March 10, 2026
The inspection concluded with zero observations, confirming the facility's compliance with current Good Manufacturing Practices
The 6th Edition NABH framework places strong emphasis on patient safety protocols, robust clinical governance, risk management systems
The EIR was issued following an inspection of the facility from November 10 to November 21, 2025
For the fourth quarter, revenue surged 47% year-on-year to Rs. 2,510 million, driven by a 23% rise in domestic sales and a 9.3x jump in export sales
The announcement follows a record-setting $1.2 million accelerated LineaDNA order
Nadda underlined that India’s policy framework is aligned with this transformation
The MoU lays the groundwork for deep academic and research collaboration in pharmaceutical technologies
The funding comes under the AHG Catalysing Innovation Awards, part of the Addiction Healthcare Goals programme led by the Office for Life Sciences
Net sales reached CHF 1,327.8 million, up 2.6% year-on-year in Swiss francs, or 4.3% at constant exchange rates
Subscribe To Our Newsletter & Stay Updated
